相关实验视频
Updated: Jan 21, 2026

36:30
Small Bowel Transplantation In Mice
Published on: August 20, 2007
15.0K
机械和口服抗生素的肠道制备与没有肠道制备用于选择性切除术 (MOBILE):多中心,随机,并行,单盲试验
Laura Koskenvuo1, Taru Lehtonen1, Selja Koskensalo1
1Department of Gastroenterological Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Lancet (London, England)
|August 13, 2019
概括
与没有肠道制备 (NBP) 相比,机械和口服抗生素肠道制备 (MOABP) 不会减少手术部位感染 (SSI) 或结肠手术中的病率. 根据这些发现,应重新考虑目前在切除术中使用MOABP的建议.
科学领域:
- 大肠直肠手术
- 预防手术感染
- 胃肠道手术
背景情况:
- 建议在结肠手术中使用机械和口服抗生素制备剂 (MOABP),以减少手术部位感染和发病率.
- 支持常规MOABP的证据是基于先前的研究,促使在前性随机试验中进行调查.
研究的目的:
- 评估MOABP与没有肠道制备 (NBP) 的有效性,以减少选择性结肠切除患者的SSI和整体发病率.
- 在结肠外科手术中挑战现有的MOABP建议.
主要方法:
- 进行了一项多中心,并行,单盲随机对照试验,涉及接受结肠切除的患者.
- 患者被随机分配 (1:1) 接受MOABP或NBP,所有参与人员的分配被掩盖.
- 主要结局是30天内SSI,使用修改的治疗意向方法进行分析.
主要成果:
- 在修改后的治疗意向分析中,共包括396名患者 (MOABP为196名,NBP为200名).
- 在MOABP组中,SSI的发生率为7%,而在NBP组中为11% (p=0. 17),没有显著的统计差异.
- 在两组中,瘤消亡和重复手术的发生率相似;在NBP组中发生了两例死亡,在MOABP组中没有死亡.
结论:
- 与没有肠道制备 (NBP) 相比,机械和口服抗生素肠道制备 (MOABP) 没有显著减少手术部位感染 (SSI) 或整体发病率.
- 这些发现表明,应重新评估常规MOABP在切除术中的建议.
相关概念视频
Irritable Bowel Syndrome I: Introduction
938
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
938
Chronic Bowel Disorders: Introduction
754
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
754
Inflammatory Bowel Disease II: Crohn's Disease
975
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
975
Inflammatory Bowel Disease I: Ulcerative Colitis
916
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
916
Inflammatory Bowel Disease V: Surgical Management
459
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
459
Inflammatory Bowel Disease IV: Pharmacological Management
538
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
538

